| Amgen (AMGN) |
United States |
$124.084B |
14.19 |
| CSL (CSLLY) |
Australia |
$95.484B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$88.687B |
11.42 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$59.632B |
54.12 |
| Biogen (BIIB) |
United States |
$56.416B |
9.63 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$48.666B |
20.61 |
| Illumina (ILMN) |
United States |
$39.683B |
41.03 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$21.285B |
9.90 |
| Seattle Genetics (SGEN) |
United States |
$19.359B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$17.724B |
0.00 |
| Incyte (INCY) |
United States |
$16.761B |
35.96 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$16.346B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$14.867B |
47.82 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$13.430B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$13.052B |
33.63 |
| Exact Sciences (EXAS) |
United States |
$12.804B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$11.564B |
54.03 |
| BeiGene (BGNE) |
Cayman Islands |
$9.685B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$8.482B |
0.00 |
| Moderna (MRNA) |
United States |
$7.996B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$7.888B |
24.29 |
| Bio-Techne Corp (TECH) |
United States |
$7.580B |
51.87 |
| BioNTech SE (BNTX) |
Germany |
$7.566B |
0.00 |
| Guardant Health (GH) |
United States |
$7.117B |
0.00 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$6.346B |
16.13 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$6.264B |
0.00 |
| Amarin (AMRN) |
Ireland |
$6.251B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$6.218B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$5.939B |
0.00 |
| Exelixis (EXEL) |
United States |
$5.895B |
19.02 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$5.850B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$4.681B |
0.00 |
| China Biologic Products (CBPO) |
China |
$4.566B |
25.72 |
| Repligen (RGEN) |
United States |
$4.423B |
80.91 |
| Bluebird Bio (BLUE) |
United States |
$4.044B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$3.730B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.611B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$3.338B |
0.00 |
| Zai Lab (ZLAB) |
China |
$3.214B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$3.202B |
0.00 |
| Immunomedics (IMMU) |
United States |
$3.179B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.172B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.145B |
249.13 |
| Genmab (GMAB) |
Denmark |
$3.130B |
12.28 |
| Emergent Biosolutions (EBS) |
United States |
$3.093B |
21.63 |
| NeoGenomics (NEO) |
United States |
$3.076B |
163.67 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$3.050B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$3.036B |
51.43 |
| MyoKardia (MYOK) |
United States |
$2.974B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$2.875B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$2.772B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$2.500B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$2.395B |
5.57 |
| UniQure (QURE) |
Netherlands |
$2.378B |
0.00 |
| Insmed (INSM) |
United States |
$2.353B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$2.296B |
0.00 |
| RA PHARMCTL INC (RARX) |
United States |
$2.200B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$2.120B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$2.089B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.957B |
0.00 |
| Alector (ALEC) |
United States |
$1.888B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.750B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.746B |
50.99 |
| Arvinas (ARVN) |
United States |
$1.620B |
0.00 |
| Akcea Therapeutics (AKCA) |
United States |
$1.606B |
37.17 |
| Zymeworks (ZYME) |
Canada |
$1.592B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.494B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.412B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.396B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.367B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$1.341B |
23.67 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.333B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$1.276B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.153B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$1.149B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$1.124B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.117B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$1.050B |
0.00 |
| Athenex (ATNX) |
United States |
$1.009B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$0.941B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$0.870B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.860B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.857B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.849B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.827B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$0.788B |
0.00 |
| Heska (HSKA) |
United States |
$0.781B |
0.00 |
| Codexis (CDXS) |
United States |
$0.758B |
0.00 |
| Vericel (VCEL) |
United States |
$0.746B |
111.27 |
| Intrexon (PGEN) |
United States |
$0.706B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.698B |
11.90 |
| Cellectis S.A (CLLS) |
France |
$0.694B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$0.682B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.640B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.640B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.621B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.612B |
5.41 |
| Anika Therapeutics (ANIK) |
United States |
$0.608B |
20.78 |
| UROGEN PHARMA (URGN) |
United States |
$0.599B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.596B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.592B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.591B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.579B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.558B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.540B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
United States |
$0.523B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.513B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.493B |
11.39 |
| Prothena (PRTA) |
Ireland |
$0.485B |
0.00 |
| NantKwest (NK) |
United States |
$0.481B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.464B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.460B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.457B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.441B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.438B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.434B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.430B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.423B |
0.00 |
| Agenus (AGEN) |
United States |
$0.408B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.407B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.406B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.405B |
0.00 |
| Pfenex (PFNX) |
United States |
$0.401B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.384B |
9.60 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.379B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.378B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.377B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.375B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.370B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.366B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.358B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.327B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.322B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.319B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.316B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.308B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.303B |
2.10 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.285B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.279B |
0.00 |
| MannKind (MNKD) |
United States |
$0.279B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.279B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.276B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.270B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.268B |
11.13 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.267B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.265B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.262B |
0.00 |
| Novavax (NVAX) |
United States |
$0.255B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.246B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.235B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.235B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.233B |
0.00 |
| IVERIC Bio (ISEE) |
United States |
$0.230B |
0.00 |
| Geron (GERN) |
United States |
$0.230B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.225B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.223B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.220B |
0.00 |
| XOMA (XOMA) |
United States |
$0.219B |
0.00 |
| Prometic Life Sciences (LMNL) |
Canada |
$0.212B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.210B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.210B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.208B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.202B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.199B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.198B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.195B |
0.00 |
| Lineage Cell Therapeutics (LCTX) |
United States |
$0.193B |
9.92 |
| Athersys (ATHX) |
United States |
$0.193B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.192B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.186B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.186B |
0.00 |
| Cerecor (CERC) |
United States |
$0.180B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.179B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.177B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.177B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.173B |
0.00 |
| Exicure (XCUR) |
United States |
$0.173B |
0.00 |
| VolitionRX (VNRX) |
Singapore |
$0.172B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.169B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.164B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.151B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.147B |
0.00 |
| Verastem (VSTM) |
United States |
$0.146B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.145B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.144B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.144B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.142B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.141B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.137B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.136B |
0.00 |
| Newron Pharmaceuticals SpA (NWPHF) |
Italy |
$0.134B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.133B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.131B |
0.00 |
| Arsanis (XFOR) |
United States |
$0.130B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.128B |
3.48 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.125B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.120B |
0.00 |
| OvaScience (MLND) |
United States |
$0.116B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.115B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.114B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.114B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.114B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.107B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.106B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.099B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.095B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.093B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.091B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.089B |
0.00 |
| Adocia (ADOCY) |
France |
$0.086B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.082B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.080B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.079B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.077B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.075B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.072B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.068B |
4.40 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.067B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.066B |
0.00 |
| Trevena (TRVN) |
United States |
$0.066B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.065B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.062B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.061B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.060B |
0.00 |
| China Health Industries Holdings (CHHE) |
China |
$0.056B |
16.98 |
| NewLink Genetics (NLNK) |
United States |
$0.055B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.053B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.052B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.048B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.046B |
0.00 |
| Curis (CRIS) |
United States |
$0.044B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.044B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.044B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.044B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.042B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.040B |
0.00 |
| AmpliPhi Biosciences (ARMP) |
United States |
$0.038B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.036B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.033B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.032B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.030B |
0.00 |
| Stellar Biotechnologies (EDSA) |
Canada |
$0.030B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.028B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.028B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.027B |
0.00 |
| Celsion (CLSN) |
United States |
$0.026B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.026B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.026B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.026B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.025B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.024B |
0.00 |
| IBio (IBIO) |
United States |
$0.024B |
0.00 |
| VIVUS (VVUS) |
United States |
$0.023B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.020B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.019B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.018B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.017B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.015B |
0.00 |
| PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.014B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.014B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.012B |
0.00 |
| Cesca Therapeutics (THMO) |
United States |
$0.012B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.012B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.011B |
0.00 |
| TrovaGene (TROV) |
United States |
$0.011B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.010B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.010B |
0.00 |
| BioPharmX (BPMX) |
United States |
$0.008B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.006B |
0.00 |
| Neuralstem (SNCA) |
United States |
$0.004B |
0.00 |
